Implanted synthetic cells trigger tissue angiogenesis through de novo production of recombinant growth factors.
Proc Natl Acad Sci U S A. 2022 Sep 20;119(38):e2207525119. doi: 10.1073/pnas.2207525119. Epub 2022 Sep 12.
Proc Natl Acad Sci U S A. 2022.
PMID: 36095208